Signed Jan 23, 2026 · Updated Jan 23, 2026
The Department of Defense placed a delivery order with Pfizer for $22,469 worth of naloxone vials. This order is part of a larger existing agreement and was made through full and open competition, making it a routine purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
$22,469
Actual federal dollars obligated to date on this award
$22,469
A maximum, not earned revenue
$652K across 10 awards
Obligations to date on awards newly signed in the last 12 months, mapped to this company
83.2% from the largest awarding agency
Share of T12M mapped obligations
Earliest mapped award on record
Within the awards OQRO has ingested
0.00% of FY2021 revenue ($81.3B)
T12M mapped obligations ÷ revenue the company reported in its 10-K. A size comparison: obligations are not revenue and are usually earned over several years
verified alias
Exact identifier > verified alias > manual override
4570864089!protonix dr 40 mg tablet 90s
Starts Feb 18, 2026Ended Feb 19, 2026
The Department of Defense placed a delivery order for $8.2K of Pfizer's Protonix DR 40 MG tablets. This order was made under an existing larger agreement and was open to any bidder, making it a routine purchase.
Compensation award — excluded from discretionary-purchase analysis.
4570680572!naloxone 4 mg/10 ml vial 10ml
Starts Jan 29, 2026Ended Jan 30, 2026
The Department of Defense placed a delivery order with Pfizer for naloxone vials, committing $2.8K so far. This order was made under an existing larger agreement and was open to any bidder, making it a routine purchase.
